<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>前免疫</title><link/>https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%20%5BNLMID%5D&amp;utm_medium=rsss。 ff = 20250210091012＆fc =无<description>前免疫：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%5BNLMID%5D&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_campaign=journals&amp;utm_source=Chrome&amp;utm_content=101560960&amp;ff=20250210091012&amp;fc=None" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>星期一，2025年2月10日14:10:14 +0000</lastbuilddate><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><ttl> 120</ttl><item><title> MUC2表达调节结直肠癌的免疫浸润</title><link/>https://pubmed.ncbi.nlm.nih.gov/39926604/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description>结论：我们的研究是第一个证明MUC2在体外结肠直肠癌（CRC）中免疫浸润的物理障碍。在HT-29细胞中，MUC2敲除增加了免疫浸润，而在LS-174T细胞中，其他粘蛋白（MUC6，MUC5B）的代偿表达保持了屏障。这些发现揭示了粘蛋白生物学在CRC中的复杂性，并表明靶向粘蛋白途径可能是一种新型的治疗方法。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 15：1500374。 doi：10.3389/fimmu.2024.1500374。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：大肠癌（CRC）是一种普遍的恶性肿瘤，全球发病率和死亡率很高。对肿瘤微环境中癌细胞与其他细胞的相互作用的相互作用更深入地了解对于设计有效的治疗策略至关重要。 MUC2是胃肠道保护性粘液层的主要组成部分，与CRC进展和免疫反应调节有关。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这项研究中，我们试图使用涉及两种完善的细胞系HT-29和LS-174T的<i>体外</i>模型来阐明CRC内MUC2表达与免疫浸润之间的关系。通过采用CRISPR介导的MUC2敲除，我们研究了MUC2对肿瘤免疫浸润的影响及其与T细胞和NK细胞的相互作用，富含外周血单核细胞（PBMC）在3D斑点培养物中的影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：尽管与HT-29相比，LS-174T细胞系中的MUC2更丰富，但其敲除导致HT-29细胞系中的免疫浸润增加，但在LS-174T细胞系中却没有。我们透露，通过在胃肠道上皮中通常表达的其他凝胶形成的粘蛋白蛋白（MUC6，MUC5B）的表达来补偿LS-174T中MUC2蛋白的去除，而在HT-29蜂窝线中未观察到。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的研究是第一个证明MUC2在<i>体外</i>结肠直肠癌（CRC）中免疫浸润的物理障碍。在HT-29细胞中，MUC2敲除增加了免疫浸润，而在LS-174T细胞中，其他粘蛋白（MUC6，MUC5B）的代偿表达保持了屏障。这些发现揭示了粘蛋白生物学在CRC中的复杂性，并表明靶向粘蛋白途径可能是一种新型的治疗方法。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39926604/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39926604</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802499/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802499</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1500374>10.3389/fimmu.2024.1500374</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39926604</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator>克里斯托夫·雷诺德（Christophe M Raynaud）</dc:creator><dc:creator> Ayesha Jabeen</dc:creator><dc:creator> Eiman I Ahmed</dc:creator><dc:creator>撒旦哈伯克</dc:creator><dc:creator>Apryl Sanchez</dc:creator><dc:creator> Shimaa Sherif</dc:creator><dc:creator>艾哈迈德A al-Shaibi</dc:creator><dc:creator>伯尼斯·罗</dc:creator><dc:creator>杰西卡·罗兰兹（Jessica Roelands）</dc:creator><dc:creator> Davide Bedognetti</dc:creator><dc:creator> Wouter Hendrickx</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>MUC2表达调节结直肠癌的免疫浸润</dc:title><dc:identifier>PMID：39926604</dc:identifier><dc:identifier> PMC：PMC11802499</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1500374</dc:identifier></item><item><title>单细胞测序揭示了DAPK1在神经胶质瘤及其诊断和预后含义中的机械作用</title><link/>https://pubmed.ncbi.nlm.nih.gov/39926603/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description>结论：基于DAPK1的预后模型显示出有望准确预测胶质母细胞瘤和胶质瘤的结果。对DAPK1在胶质母细胞瘤中的特定机制的深入研究可以阐明其在免疫疗法反应中的作用。靶向DAPK1基因可能会为神经胶质瘤患者提供治疗益处。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 15：1463747。 doi：10.3389/fimmu.2024.1463747。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：我们对神经胶质瘤中单细胞分化数据的特征进行了研究，重点是开发基于DAPK1的预后标记以预测患者的预后。 DAPK1的表达失调与包括神经胶质瘤在内的各种恶性肿瘤的侵入性行为有关。但是，DAPK1在神经胶质瘤中的确切作用和潜在机制仍然不足。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：除了来自GEO胶质瘤患者的单细胞RNA测序（SCRNA-seq）数据外，我们还对癌症基因组图集（TCGA）（TCGA）（TCGA）和基因表达综合（GEO）进行了对RNA-Seq和微阵列数据集进行了分析。利用Seurat R包，我们确定了与Scrna-Seq数据生存相关的基因簇。使用套索和逐步回归算法开发了预后模型。此外，我们评估了这些基因在免疫微环境中的预测潜力及其在免疫疗法环境中的相关性。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们的SCRNA-SEQ数据分析显示了32个与10个细胞类型相对应的不同细胞簇。通过降低维度和聚类，我们根据其分化轨迹确定了三个神经胶质细胞亚群。 DAPK1充当末端亚群的标记基因，表现出与预后不良的关联。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：基于DAPK1的预后模型显示出有望准确预测胶质母细胞瘤和胶质瘤的结果。对DAPK1在胶质母细胞瘤中的特定机制的深入研究可以阐明其在免疫疗法反应中的作用。靶向DAPK1基因可能会为神经胶质瘤患者提供治疗益处。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39926603/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39926603</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802534/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802534</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1463747>10.3389/fimmu.2024.1463747</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39926603</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator>天阳</dc:creator><dc:creator>Yan-yu ding</dc:creator><dc:creator> Si-guo Zhao</dc:creator><dc:creator> Jie-Hui Zhao</dc:creator><dc:creator> Yu Gu</dc:creator><dc:creator>董陈</dc:creator><dc:creator>方张</dc:creator><dc:creator>温敏洪</dc:creator><dc:date>2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>单细胞测序揭示了DAPK1在神经胶质瘤及其诊断和预后含义中的机械作用</dc:title><dc:identifier>PMID：39926603</dc:identifier><dc:identifier> PMC：PMC11802534</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1463747</dc:identifier></item><item><title>在疫苗接种挑战研究中，使用糖蛋白G缺失突变体疫苗疫苗的临床评估和转录组分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/39926602/?utm_source = chrome&amp;utm_medium = rsss＆campaign = Journals&amp;utm_campaign = Journals&amp;utm_content = 101560960＆fc = none＆fc = none&amp;ff=20220250210220250220210225022021022021022021022021022502102202102202102201220210220122022012259METER/范围内<description>糖蛋白G污染的感染性喉咙病毒病毒（ILTV）ΔGG-tiltv的糖蛋白-G污染疫苗菌株是安全有效的，以防止ILTV挑战。在当前的研究中，将ΔGG-TILDV接种疫苗的外周血单核细胞（PBMC）的转录组与疫苗发生后7天的非接种式鸡肉的转录与无接种疫苗的鸡的转录组进行了比较。在...组的组之间比较了挑战性ILTV之后的气管转录组</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 15：1458218。 doi：10.3389/fimmu.2024.1458218。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">糖蛋白G污染的感染性喉咙病毒病毒（ILTV）ΔGG-tiltv的糖蛋白-G污染疫苗菌株是安全有效的，以防止ILTV挑战。在当前的研究中，将ΔGG-TILDV接种疫苗的外周血单核细胞（PBMC）的转录组与疫苗发生后7天的非接种式鸡肉的转录与无接种疫苗的鸡的转录组进行了比较。比较了毒性ILTV之后的气管转录组在非疫苗接种挑战的组和接种疫苗的挑战者以及未感染的挑战和未感染的鸡和未感染的鸡之间，在挑战后4至5天。还评估了这些组之间挑战之后的临床结果。与其他两组相比，在非疫苗接种挑战的鸟类的气管转录组中观察到了显着差异。富集的基因本体和途径表明对纤毛和神经元功能，细胞连接组件的免疫反应增强以及对软骨和细胞外成分的潜在损害，对非vaccinaled挑战的鸟类的软骨和细胞外成分的潜在损害与它们的严重气管病理学相比一致其他两个组。相反，通过在两组中保留气管粘膜完整性以及在接种疫苗的挑战者挑战的鸟类中的轻度浸润，反映了接种挑战和未感染的鸟类之间气管转录组的任何差异。这项研究的结果表明，使用ΔGG-TILDV疫苗接种阻止了在ILTV挑战期间引起的气管转录组的变化，从而获得了临床保护。此外，这些结果还提供了对ILTV感染引起的气管病理学基础的分子机制的见解。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39926602/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39926602</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802539/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802539</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1458218>10.3389/fimmu.2024.1458218</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39926602</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Gayathri Gopakumar</dc:creator><dc:creator> Mauricio JC Coppo</dc:creator><dc:creator> AndrésIaz-Méndez</dc:creator><dc:creator>卡罗尔·哈特利（Carol A Hartley）</dc:creator><dc:creator>乔安妮·德·德夫林（Joanne M Devlin）</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>在疫苗接种挑战研究中，使用糖蛋白G缺失突变体疫苗疫苗的临床评估和转录组分析</dc:title><dc:identifier>PMID：39926602</dc:identifier><dc:identifier> PMC：PMC11802539</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1458218</dc:identifier></item><item><title> &lt;em>;胸腺AD ASTARA &lt;/em>;或太空飞行诱导的胸腺差异</title><link/>https://pubmed.ncbi.nlm.nih.gov/39926601/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description> SpaceFlight施加了一个生理挑战式辐射，微重力，破坏的昼夜节律和社会心理压力的星座 - 严重损害了宇航员的健康。在最脆弱的器官中，是免疫系统功能的基石胸腺，其任务是生成适应性免疫必不可少的天真T细胞。胸腺对太空飞行条件特别敏感，因为它在维持免疫稳态方面的作用受A ...的严格调节。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 15：1534444。 doi：10.3389/fimmu.2024.1534444。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> SpaceFlight施加了一个生理挑战式辐射，微重力，破坏的昼夜节律和社会心理压力的星座 - 严重损害了宇航员的健康。在最脆弱的器官中，是免疫系统功能的基石胸腺，其任务是生成适应性免疫必不可少的天真T细胞。胸腺对太空飞行条件特别敏感，因为它在维持免疫稳态的作用受到空间容易破坏的系统性和局部因素的平衡的严格调节。宇宙辐射是地球磁层以外的无处不在危险，可加速胸腺上皮细胞中的DNA损伤和细胞衰老，损害胸腺胞菌并增加了免疫失调的风险。微重力和昼夜节律破坏通过改变免疫细胞迁移模式和基质支持来加剧这一点，这对于T细胞发育至关重要。社会心理压力源，包括长时间的隔离和任务引起的焦虑，通过升高全身性糖皮质激素水平来进一步复合胸腺萎缩。模拟宇宙辐射和微重力的地面类似物在阐明胸腺涉及的机制及其对免疫力的下游影响方面发挥了作用。这些模型表明，长期的任务导致幼稚的T细胞输出减少，使宇航员容易受到感染的影响，并且可能患有肿瘤的高风险。对策的进展，例如针对胸腺再生的药理学干预措施和保护胸腺建筑的生物工程方法，它是在长时间探索过程中保留免疫弹性的重要策略。专注于胸腺作为免疫脆弱性的中心枢纽，强调了其在太空飞行引起的健康风险中的关键作用。了解这些动态不仅会增强人类空间任务的安全性，而且还可以在极端条件下对胸腺生物学的关键见解。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39926601/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39926601</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802524/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802524</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1534444>10.3389/fimmu.2024.1534444</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39926601</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Wataru Muramatsu</dc:creator><dc:creator>玛丽亚·玛丽亚诺维奇（Maria Maryanovich）</dc:creator><dc:creator> Taishin Akiyama</dc:creator><dc:creator>乔治·卡拉吉安尼斯</dc:creator><dc:date>2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>&lt;em>;胸腺AD ASTARA &lt;/em>;或太空飞行诱导的胸腺差异</dc:title><dc:identifier>PMID：39926601</dc:identifier><dc:identifier> PMC：PMC11802524</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1534444</dc:identifier></item><item><title> Pan-Canter和实验分析揭示了CST2的免疫治疗意义及其与胃腺癌增殖和转移的关联</title><link/>https://pubmed.ncbi.nlm.nih.gov/39926600/？<description>结论：CST2是潜在的肿瘤免疫生物标志物，在Stad的增殖和迁移过程中起着至关重要的促进作用。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 15：1466806。 doi：10.3389/fimmu.2024.1466806。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：半胱氨酸2（CST2）是半胱氨酸蛋白酶抑制剂，最近的研究表明其潜在参与癌症的发展。然而，尚未系统地研究其在泛伴奏中的发生，进展和预后的作用。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">材料和方法：这项研究全面分析了泛伴侣中CST2的差异表达。使用单细胞数据集检查了CST2的表达分布模式。此外，我们对CST2表达与各种因素之间的相关性进行了全面评估。这些因素包括预后，免疫细胞浸润，与免疫相关的基因，突变，甲基化，肿瘤突变负担（TMB）和微卫星不稳定性（MSI）。此外，我们分析了依赖CST2表达的药物的敏感性。我们利用基因集富集分析（GSEA）分析来探索不同癌症类型的CST2的生物学功能。最后，在胃癌细胞系中，我们将研究CST2敲除对表达水平，克隆增殖，细胞凋亡和细胞迁移的影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：CST2在多个肿瘤中表现出异常的过表达。单细胞分析揭示了成纤维细胞中CST2的高表达。 CST2与预后，免疫细胞浸润，免疫相关基因，突变，甲基化，TMB和MSI密切相关。富集分析表明，CST2与免疫相关途径之间存在显着相关性。在胃腺癌（Stad）中，与CST2相关的风险模型与预后相关，并且表现出强大的预测能力，同时也与免疫微环境密切相关。药物敏感性分析表明CST2和21化学疗法药物之间的相关性。最后，实验验证显示，CST2在Stad中的表达显着升高，表明其作为驱动基因在调节恶性细胞增殖和迁移中的作用。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：CST2是潜在的肿瘤免疫生物标志物，在Stad的增殖和迁移过程中起着至关重要的促进作用。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39926600/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39926600</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802563/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802563</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1466806>10.3389/fimmu.2024.1466806</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39926600</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator>丹黄</dc:creator><dc:creator>Jing li</dc:creator><dc:creator> zhijun他</dc:creator><dc:creator>Wenjing Liang</dc:creator><dc:creator>高宗</dc:creator><dc:creator>Jun Huang</dc:creator><dc:creator> Yinteng Wu</dc:creator><dc:creator> Shijian Zhao</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>Pan-Canter和实验分析揭示了CST2的免疫治疗意义及其与胃腺癌增殖和转移的关联</dc:title><dc:identifier>PMID：39926600</dc:identifier><dc:identifier> PMC：PMC11802563</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1466806</dc:identifier></item><item><title>矫正：鉴定严重和关键covid患者SARS-COV-2感染后继发感染的危险因素-19</title><link/> https://pubmed.ncbi.nlm.nih.gov/39926599/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description> [这纠正了文章doi：10.3389/fimmu.2021.715023。]。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 15：1548101。 doi：10.3389/fimmu.2024.1548101。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> [这纠正了文章doi：10.3389/fimmu.2021.715023。]。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39926599/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39926599</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11803462/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11803462</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1548101>10.3389/fimmu.2024.1548101</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39926599</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> mingquan guo</dc:creator><dc:creator> Menglu Gao</dc:creator><dc:creator> Jing Gao</dc:creator><dc:creator> Tengfei Zhang</dc:creator><dc:creator> Xin Jin</dc:creator><dc:creator>简·范</dc:creator><dc:creator>Qianying Wang</dc:creator><dc:creator> Xin li</dc:creator><dc:creator>陈陈</dc:creator><dc:creator>Zhaoqin Zhu</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>矫正：鉴定严重和关键covid患者SARS-COV-2感染后继发感染的危险因素-19</dc:title><dc:identifier> PMID：39926599</dc:identifier><dc:identifier> PMC：PMC11803462</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1548101</dc:identifier></item><item><title>通过SCRNA-SEQ和机器学习来解密与金属离子传输相关基因在T2D发病机理和免疫细胞浸润中的作用</title><link/>https://pubmed.ncbi.nlm.nih.gov/39926598/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description>结论：我们的分析确定了对T2D至关重要的基因，强调离子转运，信号传导和免疫细胞相互作用。这些发现表明了增强T2D管理的治疗潜力。所鉴定的途径和基因为疾病机制和潜在的干预目标提供了宝贵的见解。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 15：1479166。 doi：10.3389/fimmu.2024.1479166。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：2型糖尿病（T2D）是一种复杂的代谢障碍，具有重大的全球健康影响。了解T2D的分子机制对于制定有效的治疗策略至关重要。这项研究采用单细胞RNA测序（SCRNA-SEQ）和机器学习来探索T2D的发病机理，特别关注免疫细胞浸润。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们分析了来自T2D和非糖尿病（ND）患者胰岛细胞的SCRNA-SEQ数据，以鉴定出差异表达的基因（DEG），尤其是与金属离子转运（RMITRGS）有关的基因。我们采用了12种机器学习算法来开发预测模型，并使用单样本基因集富集分析（SSGSEA）评估了免疫细胞浸润。研究了免疫细胞与关键RMITRG之间的相关性，并通过蛋白质 - 蛋白质相互作用（PPI）网络分析探索了这些基因之间的相互作用。此外，我们进行了详细的细胞通信分析，以识别T2D中的重要信号通路。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们的分析确定了T2D和ND患者之间的1953摄氏度，其stepglm [向后]加上GBM模型，表明了高预测精度并鉴定了13个HUB RMITRG。使用AlphaFold 3预测了十二种蛋白质结构，揭示了潜在的功能构象。我们观察到轮毂RMITRG和免疫细胞之间存在很强的相关性，PPI网络分析揭示了关键的相互作用。细胞 - 细胞通信分析强调了16个主动信号通路，具有CXCL，MIF和与免疫和炎症反应相关的补体，Wnt，Kit，LIFR和HGF途径在T2D中唯一激活。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的分析确定了对T2D至关重要的基因，强调离子转运，信号传导和免疫细胞相互作用。这些发现表明了增强T2D管理的治疗潜力。所鉴定的途径和基因为疾病机制和潜在的干预目标提供了宝贵的见解。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39926598/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39926598</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802808/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802808</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1479166>10.3389/fimmu.2024.1479166</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39926598</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Zuhui PU</dc:creator><dc:creator>托尼·鲍伊·王（Tony Bowei Wang）</dc:creator><dc:creator> lu</dc:creator><dc:creator> Zijing Wu</dc:creator><dc:creator> Yuxian Chen</dc:creator><dc:creator> Ziqi Luo</dc:creator><dc:creator> Xinyu Wang</dc:creator><dc:creator> Lisha Mou</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>通过SCRNA-SEQ和机器学习来解密与金属离子传输相关基因在T2D发病机理和免疫细胞浸润中的作用</dc:title><dc:identifier>PMID：39926598</dc:identifier><dc:identifier> PMC：PMC11802808</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1479166</dc:identifier></item><item><title>新型免疫色谱测试，用于快速检测抗因子H自身抗体，并评估其临床相关性</title><link/>https://pubmed.ncbi.nlm.nih.gov/39926597/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description>因子H（FH）是一种至关重要的补体调节剂，可防止补体介导的对健康细胞和组织的损伤。该调节功能可能会受到h自身抗体（FHAA）的破坏，然后导致疾病，例如非典型溶血性尿毒症综合征（AHUS）和C3肾小球病（C3G）。在小儿艾哈斯（Ahus）中，FHAA发病率约为10-15％，尽管在印度人口中，它上升到约50％。 FHAS靶向的FH的特定区域与...的致病机理相关</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 15：1527016。 doi：10.3389/fimmu.2024.1527016。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">因子H（FH）是一种至关重要的补体调节剂，可防止补体介导的对健康细胞和组织的损伤。该调节功能可能会受到h自身抗体（FHAA）的破坏，然后导致疾病，例如非典型溶血性尿毒症综合征（AHUS）和C3肾小球病（C3G）。在小儿艾哈斯（Ahus）中，FHAA发病率约为10-15％，尽管在印度人口中，它上升到约50％。 FHA靶向的FH的特定区域与相关疾病的致病机制相关。在Ahus中，FHAA针对C末端，从而影响FH识别细胞表面的能力。相反，在C3G中，FHAA通常以N末端为目标，从而产生获得的功能性FH缺乏。检测和监测FHAA具有有效治疗患者的决定性作用。当前的FHAA分析通常识别使用ELISA技术结合表面结合FH的游离FHAA。这些方法需要设备齐全的实验室和合格的员工，并且不衡量FH-FHAA复合体，这可能使滴度与临床结果相关联。本文所述的基于视觉的免疫色谱测试（ICT）允许在人EDTA-Plasma或血清中快速检测和定量IgG和IgM FH-FHAA复合物。与ELISA相比，该ICT可改善对FHAA的检测，因为ICT鉴定出与游离FHAA ELISA测试的样品中的FH-FHAA复合物所证明的那样。重要的是，ICT间接地告知与FHAA复杂的FH数量，从而评估了FHAA在破坏FH调节功能方面的重要性。总体而言，这种新颖的测定方法提供了一种简单，快速，成本效益，并且可能与临床上相关的替代方案，用于诊断高危人群中的FHAA。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39926597/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39926597</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802491/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802491</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1527016>10.3389/fimmu.2024.1527016</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39926597</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator>圣地亚哥·罗德里格斯·德·科尔多巴</dc:creator><dc:creator>Andrea Reparaz</dc:creator><dc:creator>丹尼尔·桑切斯（Daniel Sanchez）</dc:creator><dc:creator>希拉·平托（Sheila Pinto）</dc:creator><dc:creator>露西亚·胡纳·洛佩兹（Lucia Juana Lopez）</dc:creator><dc:creator> HéctorMartin Merinero</dc:creator><dc:creator>艾里亚·卡尔维特（Iria Calvete）</dc:creator><dc:creator>朱利安·佩雷斯·佩雷斯（Julian Perez-Perez）</dc:creator><dc:creator>悉尼S果冻</dc:creator><dc:creator>Yuzhou Zhang</dc:creator><dc:creator>理查德·史密斯（Richard JH Smith）</dc:creator><dc:creator> Inmaculada Moreno</dc:creator><dc:creator>梅赛德斯·多明格斯（Mercedes Dominguez）</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>新型免疫色谱测试，用于快速检测抗因子H自身抗体，并评估其临床相关性</dc:title><dc:identifier>PMID：39926597</dc:identifier><dc:identifier> PMC：PMC11802491</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1527016</dc:identifier></item><item><title>衰老会损害对实体瘤的收养T细胞治疗中的CD8 T细胞反应</title><link/>https://pubmed.ncbi.nlm.nih.gov/39925817/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description> T细胞介导的免疫力中与年龄相关的缺陷可以增加癌症的风险，但是衰老如何影响癌症的收养T细胞疗法（ACT）仍不清楚。在这里，使用黑色素瘤的小鼠模型，我们证明衰老会减少在实体瘤的ACT中表达肿瘤特异性T细胞受体（CD8 TCR-T细胞）的工程CD8 T细胞的抗肿瘤活性。老化的CD8 TCR-T细胞无法控制年轻小鼠或老年小鼠的肿瘤生长。老化的CD8 TCR-T细胞无法... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 16：1484303。 doi：10.3389/fimmu.2025.1484303。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> T细胞介导的免疫力中与年龄相关的缺陷可以增加癌症的风险，但是衰老如何影响癌症的收养T细胞疗法（ACT）仍不清楚。在这里，使用黑色素瘤的小鼠模型，我们证明衰老会减少在实体瘤的ACT中表达肿瘤特异性T细胞受体（CD8 TCR-T细胞）的工程CD8 T细胞的抗肿瘤活性。老化的CD8 TCR-T细胞无法控制年轻小鼠或老年小鼠的肿瘤生长。与年轻细胞相比，老化的CD8 TCR-T细胞无法在肿瘤中有效积累，并且具有较高的术语耗尽的T细胞，其含量耗尽的T细胞的表达较低。 CRISPR介导的<i>EPAS1</i>的消融可促进肿瘤中年轻CD8 T细胞的末端衰竭，从而减少其在幼鼠中的抗肿瘤活性。相反，EPAS1的逆转录病毒表达增强了老化CD8 TCR-T细胞的抗肿瘤活性。这些发现表明，衰老诱导的EPAS1表达的降低会损害CD8 T细胞对实体瘤的抗肿瘤活性，这可以通过表达外源性EPAS1的表达来治疗。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39925817/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39925817</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11803149/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11803149</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1484303>10.3389/fimmu.2025.1484303</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39925817</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Gulfiya Kadyrzhanova</dc:creator><dc:creator> Miho Tamai</dc:creator><dc:creator> Shukla Sarkar</dc:creator><dc:creator> Rajkumar Singh Kalra</dc:creator><dc:creator> Hiroki Ishikawa</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>衰老会损害对实体瘤的收养T细胞治疗中的CD8 T细胞反应</dc:title><dc:identifier>PMID：39925817</dc:identifier><dc:identifier> PMC：PMC11803149</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1484303</dc:identifier></item><item><title>时间限制的喂养通过激活棕色脂肪组织的热发生并减少炎症标记来改善代谢综合征</title><link/>https://pubmed.ncbi.nlm.nih.gov/39925816/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description>结论：这项研究表明，TRF可以激活棕色脂肪组织中的热发生并减少炎症制造剂，从而改善肝脂肪变性并减少白脂肪组织的积累。这些发现表明，TRF可能是缓解与肥胖和代谢综合征相关的代谢障碍的有希望的干预措施。该研究提供了对TRF的有益作用的机理见解，突出了其调节脂质的潜力。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 16：1501850。 doi：10.3389/fimmu.2025.1501850。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：肥胖和代谢综合征（METS）已成为越来越重大的全球健康问题。作为一种新颖的饮食干预，受时间限制的喂养（TRF）近年来引起了人们的关注。但是，有限的研究重点是TRF对能量消耗和系统性低度炎症的影响。这项研究旨在研究TRF对雄性C57BL/6J小鼠体重管理，葡萄糖代谢，胰岛素抵抗和脂质代谢的影响，尤其是在高脂饮食引起的代谢疾病的情况下（HFD）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：将C57BL/6J小鼠分为两组：正常饮食（ND）组和一个高脂饮食（HFD）组。研究持续时间为12周。观察到的关键参数包括体重，葡萄糖耐量（通过葡萄糖耐受性测试），胰岛素抵抗（HOMA-IR）和葡萄糖刺激下的胰岛素分泌。此外，对肝组织进行油红O染色以评估脂质积累，并用苏木精和曙红（HE）染色白色和棕色的脂肪组织，以评估脂肪细胞的大小。还测量了肝脂肪形成相关基因（SREBP-C，CHREBP，FASN和ACC1）的表达和棕色脂肪组织（UCP1和PGC-1α）中的热基因的表达。此外，监测Xapular棕色脂肪组织（BAT）的温度变化。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在ND组中：TRF提高了胰岛素抵抗和促炎性细胞因子IL-6的循环水平，体重略有降低。在HFD组中：TRF显着缓解了体重增加，改善了葡萄糖耐受性和胰岛素抵抗力，并在葡萄糖刺激下增强了胰岛素分泌。另外，TRF通过下调肝脏中与脂肪生成相关的基因的表达来降低肝脂肪变性。 TRF还通过上调BAT中的热基因（UCP1和PGC-1α）的表达来增加热发生，同时降低血清促炎细胞因子IL-6和TNF-α的血清水平，尽管IL-1β水平保持不变。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这项研究表明，TRF可以激活棕色脂肪组织中的热发生并减少炎症制造剂，从而改善肝脂肪变性并减少白脂肪组织的积累。这些发现表明，TRF可能是缓解与肥胖和代谢综合征相关的代谢障碍的有希望的干预措施。该研究提供了对TRF的有益作用的机械见解，突出了其在调节脂质代谢和发挥抗炎作用方面的潜力。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39925816/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39925816</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802511/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802511</a> | doi： <a href=https://doi.org/10.3389/fimmu.2025.1501850>10.3389/fimmu.2025.1501850</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39925816</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> y锣</dc:creator><dc:creator>张张</dc:creator><dc:creator>江冯</dc:creator><dc:creator>李伊</dc:creator><dc:creator>孟门吉</dc:creator><dc:creator>Shiyin Wei</dc:creator><dc:creator> Qiming MA</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>时间限制的喂养通过激活棕色脂肪组织的热发生并减少炎症标记来改善代谢综合征</dc:title><dc:identifier>PMID：39925816</dc:identifier><dc:identifier> PMC：PMC11802511</dc:identifier><dc:identifier> doi：10.3389/fimmu.2025.1501850</dc:identifier></item><item><title>原生动物和蠕虫寄生虫诱导的中性粒细胞外陷阱的文献计量分析（2008-2024）</title><link/> https://pubmed.ncbi.nlm.nih.gov/39925815/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description>结论：这项研究提供了对网和寄生虫的全面概述和视觉分析，突出了未来研究的关键领域。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月24日； 16：1498453。 doi：10.3389/fimmu.2025.1498453。环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：寄生疾病构成了重大的全球公共卫生挑战，影响了数十亿人，并在牲畜和家禽中造成了重大的经济损失。在与这些感染的斗争中，中性粒细胞采用各种策略，包括释放中性粒细胞外陷阱（NETS）。最近的研究在理解原生动物和蠕虫触发的网中取得了重大进展。但是，仍然缺乏一项综合的文献计量分析，该分析汇编了这些发现并确定该领域的研究热点和趋势仍然缺乏。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们利用科学核心收集和Scopus数据库来检索原生动物和蠕虫引起的网络的原始文章。筛选后，将数据传输到可视化工具Vosviewer，Biblioshiny和Citespace进行分析。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们的研究包括159篇发表在69篇期刊上的原始文章，其中涉及来自41个国家 /地区270个机构的909位作者。德国和巴西为网络和寄生虫的研究做出了最重要的贡献，分别为45和32个出版物以及1,495和1,342次引用。 Carlos Hermosilla和Anja Taubert（德国的Justus Liebig University）和Elvira Saraiva（巴西里约热内卢联邦大学）都是该领域的领导者，无论是出版物和引文而言。<i>免疫学领域的边界</i>一直对该领域产生了一致和显着影响，并且在<i>美国国家科学院会议录</i>中的一篇文章提供了寄生虫的第一个直接释放的直接证据。当前的研究侧重于疟疾，<i>弓形虫弓形虫</i>， <i>besnoitia besnoiti</i> ，nematodes以及网络产量的机制及其对寄生虫和宿主细胞的影响。新兴趋势包括对不同宿主和寄生虫物种的网络的治疗靶向和比较研究。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: This study offers a comprehensive overview and visual analysis of NETs and parasites, highlighting key areas for future research.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39925815/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39925815</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802541/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802541</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1498453>10.3389/fimmu.2025.1498453</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39925815</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Tamara Muñoz-Caro</dc:creator><dc:creator> Elvira M Saraiva</dc:creator><dc:creator> Rafael M Mariante</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>Bibliometric analysis of neutrophil extracellular traps induced by protozoan and helminth parasites (2008-2024)</dc:title><dc:identifier> pmid:39925815</dc:identifier><dc:identifier> pmc:PMC11802541</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1498453</dc:identifier></item><item><title> Mechanisms and environmental factors shaping the ecosystem of brain macrophages</title><link/> https://pubmed.ncbi.nlm.nih.gov/39925814/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description> Brain macrophages encompass two major populations: microglia in the parenchyma and border-associated macrophages (BAMs) in the extra-parenchymal compartments. These cells play crucial roles in maintaining brain homeostasis and immune surveillance. Microglia and BAMs are phenotypically and epigenetically distinct and exhibit highly specialized functions tailored to their environmental niches. Intriguingly, recent studies have shown that both microglia and BAMs originate from the same myeloid... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Front Immunol</b> . 2025 Jan 24;16:1539988. doi: 10.3389/fimmu.2025.1539988.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Brain macrophages encompass two major populations: microglia in the parenchyma and border-associated macrophages (BAMs) in the extra-parenchymal compartments. These cells play crucial roles in maintaining brain homeostasis and immune surveillance. Microglia and BAMs are phenotypically and epigenetically distinct and exhibit highly specialized functions tailored to their environmental niches. Intriguingly, recent studies have shown that both microglia and BAMs originate from the same myeloid progenitor during yolk sac hematopoiesis, but their developmental fates diverge within the brain. Several works have partially unveiled the mechanisms orchestrating the development of microglia and BAMs in both mice and humans; however, many questions remain unanswered. Defining the molecular underpinnings controlling the transcriptional and epigenetic programs of microglia and BAMs is one of the upcoming challenges for the field. In this review, we outline current knowledge on ontogeny, phenotypic diversity, and the factors shaping the ecosystem of brain macrophages. We discuss insights garnered from human studies, highlighting similarities and differences compared to mice. Lastly, we address current research gaps and potential future directions in the field. Understanding how brain macrophages communicate with their local environment and how the tissue instructs their developmental trajectories and functional features is essential to fully comprehend brain physiology in homeostasis and disease.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39925814/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39925814</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802581/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802581</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1539988>10.3389/fimmu.2025.1539988</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39925814</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Silvia Penati</dc:creator><dc:creator> Simone Brioschi</dc:creator><dc:creator> Zhangying Cai</dc:creator><dc:creator> Claudia Z Han</dc:creator><dc:creator> Marco Colonna</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>Mechanisms and environmental factors shaping the ecosystem of brain macrophages</dc:title><dc:identifier> pmid:39925814</dc:identifier><dc:identifier> pmc:PMC11802581</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1539988</dc:identifier></item><item><title> Exhaustion of CD8&lt;sup>;pos&lt;/sup>; central memory regulatory T cell differentiation is involved in renal allograft rejection</title><link/> https://pubmed.ncbi.nlm.nih.gov/39925813/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description> CONCLUSIONS: Our results show that exhaustive CD8^(pos) Treg differentiation into CM Tregs may lead to future rejection, with a shift towards EM Treg production and an accumulation of CD31^(neg) TEMRA Tregs in KTR with current rejection. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Front Immunol</b> . 2025 Jan 24;16:1532086. doi: 10.3389/fimmu.2025.1532086.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: The role of regulatory CD8 <sup>pos</sup> T cells (CD8 <sup>pos</sup> Tregs) and cytotoxic CD8 <sup>pos</sup> responder T cells (CD8 <sup>pos</sup> Tresps) in maintaining stable graft function in kidney transplant recipients (KTR) remains largely unclear. The pathogenesis of graft deterioration in case of rejection involves the exhaustive differentiation of both CD8 <sup>pos</sup> T cell subsets, but the causal mechanisms have not yet been identified. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: In this study, we separately investigated the differentiation of CD8 <sup>pos</sup> Tregs/Tresps in 134 stable KTR with no evidence of renal graft rejection, in 41 KTR diagnosed with biopsy-confirmed rejection at enrolment and in 5 patients who were unremarkable at enrolment, but developed rejection within three years of enrolment. We were investigating whether changed differentiation of CCR7 <sup>pos</sup> CD45RA <sup>pos</sup> CD31 <sup>pos</sup> recent thymic emigrant (RTE) cells via CD45RA <sup>neg</sup> CD31 <sup>pos</sup> memory (CD31 <sup>pos</sup> memory) cells (pathway 1), via direct proliferation (pathway 2), or via CCR7 <sup>pos</sup> CD45RA <sup>+</sup> CD31 <sup>neg</sup> resting mature naïve (MN) cells (pathway 3) into CD45RA <sup>neg</sup> CD31 <sup>neg</sup> memory (CD31 <sup>neg</sup> memory) cells affects the CD8 <sup>pos</sup> Treg/Tresp ratio or identifies a CD8 <sup>pos</sup> Treg/Tresp subset that predicts or confirms renal allograft rejection 。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: We found that RTE Treg differentiation via pathway 1 was age-independently increased in KTR, who developed graft rejection during the follow-up period, leading to abundant MN Treg and central memory Treg (CM Treg) production and favoring a strongly increased CD8 <sup>pos</sup> Treg/Tresp ratio. In KTR with biopsy-confirmed rejection at the time of enrolment, an increased differentiation of RTE Tregs into CCR7 <sup>neg</sup> CD45RA <sup>pos</sup> CD31 <sup>neg</sup> terminally differentiated effector memory (CD31 <sup>neg</sup> TEMRA Tregs) and CD31 <sup>pos</sup> memory Tregs was observed. CD31 <sup>neg</sup> memory Treg production was maintained by alternative differentiation of resting MN Tregs, resulting in increased effector memory Treg (EM Treg) production, while the CD8 <sup>pos</sup> Treg/Treg ratio was unaffected. An altered differentiation of CD8 <sup>pos</sup> Tresps was not observed, shifting the Treg/Tresp ratio in favor of Tregs. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: Our results show that exhaustive CD8 <sup>pos</sup> Treg differentiation into CM Tregs may lead to future rejection, with a shift towards EM Treg production and an accumulation of CD31 <sup>neg</sup> TEMRA Tregs in KTR with current rejection.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39925813/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39925813</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802571/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802571</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1532086>10.3389/fimmu.2025.1532086</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39925813</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Florian Kälble</dc:creator><dc:creator> Jonas Leonhard</dc:creator><dc:creator> Martin Zeier</dc:creator><dc:creator> Oliver Zivanovic</dc:creator><dc:creator> Matthias Schaier</dc:creator><dc:creator> Andrea Steinborn</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>Exhaustion of CD8&lt;sup>;pos&lt;/sup>; central memory regulatory T cell differentiation is involved in renal allograft rejection</dc:title><dc:identifier> pmid:39925813</dc:identifier><dc:identifier> pmc:PMC11802571</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1532086</dc:identifier></item><item><title> Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension</title><link/> https://pubmed.ncbi.nlm.nih.gov/39925812/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description> CONCLUSION: OIP with intracranial extension is uncommon. More than half of patients with OIP with intracranial extension may be satisfactorily treated with corticosteroids combined with immunosuppressants. However, for patients who still experience recurrence or slow reduction of lesions after applying this combined therapy, RTX may be a better option. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Front Immunol</b> . 2025 Jan 24;16:1516909. doi: 10.3389/fimmu.2025.1516909.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> OBJECTIVE: The aim of this study was to compare the efficacy of low-dose rituximab (RTX) and immunosuppressants in treating orbital inflammatory pseudotumor (OIP) with intracranial extension, a refractory and high-relapse disease. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: Patients who had been diagnosed with refractory OIP with intracranial extension and who were refractory to systemic corticosteroids were retrospectively recruited at the Neuro-Ophthalmology Department at the Chinese People&#39;s Liberation Army General Hospital between December 2018 and September 2022. After methylprednisolone pulse therapy, we added 2 mg of tacrolimus per day, 1500 mg of mycophenolate mofetil per day, or 200 mg of rituximab at days 1 and 15, and then monitored those with CD19+ B cells of under 1% as adjuvant therapy. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Eleven patients (six males and five females) were included, with a mean age of 45.5 ± 11.8 years (age range: 21-64 years). The average follow-up period was 3.8 years (range: 2-5). Eight patients (72.7%) had different levels of decreased vision at onset of the illness and four patients (36.4%) had severely impaired vision (three with no light perception, one with some light perception). Four patients (36.4%) showed clinical course worsening or lack of remission when treated with corticosteroids. Seven patients (63.6%) had a typical relapsing course, and the annual recurrence rate was higher than 7.36 ± 3.73 times. Of these seven, four (57.1%, 4/7) were able to undergo successful management with immunosuppressants. Three (42.9%, 3/7) failed with immunosuppressants but succeeded in controlling relapse with RTX. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: OIP with intracranial extension is uncommon. More than half of patients with OIP with intracranial extension may be satisfactorily treated with corticosteroids combined with immunosuppressants. However, for patients who still experience recurrence or slow reduction of lesions after applying this combined therapy, RTX may be a better option.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39925812/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39925812</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802561/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802561</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1516909>10.3389/fimmu.2025.1516909</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39925812</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Yuyu Li</dc:creator><dc:creator> Mingming Sun</dc:creator><dc:creator> Xintong Xu</dc:creator><dc:creator> Biyue Chen</dc:creator><dc:creator> Xiyun Chen</dc:creator><dc:creator> Yuhang Wang</dc:creator><dc:creator> Quangang Xu</dc:creator><dc:creator> Huanfen Zhou</dc:creator><dc:creator> Shihui Wei</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension</dc:title><dc:identifier> pmid:39925812</dc:identifier><dc:identifier> pmc:PMC11802561</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1516909</dc:identifier></item><item><title> Distal muscle weakness as the main onset symptom in thymoma-associated myasthenia gravis: a case report and literature review</title><link/> https://pubmed.ncbi.nlm.nih.gov/39925811/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250210091012&amp;v=2.18.0.post9+e462414<description> Myasthenia gravis (MG) is an autoimmune disorder within the spectrum of neuromuscular rare diseases, characterized by fluctuating muscle weakness. This report presents a case of a middle-aged woman with a chronic onset of asymmetric upper limb weakness accompanied by difficulty in finger extension, without ptosis or fluctuation for 4 years. The patient was finally diagnosed with MG by a significant decrement of Compound Muscle Action Potential in repetitive nerve stimuli, positive... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Front Immunol</b> . 2025 Jan 24;16:1498847. doi: 10.3389/fimmu.2025.1498847.环保2025。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Myasthenia gravis (MG) is an autoimmune disorder within the spectrum of neuromuscular rare diseases, characterized by fluctuating muscle weakness. This report presents a case of a middle-aged woman with a chronic onset of asymmetric upper limb weakness accompanied by difficulty in finger extension, without ptosis or fluctuation for 4 years. The patient was finally diagnosed with MG by a significant decrement of Compound Muscle Action Potential in repetitive nerve stimuli, positive anti-acetylcholine receptor antibodies as well as the presence of a mass located in the anterior mediastinum. With subsequent immunotherapies for one month, the patient exhibited marked enhancement in muscle strength, followed by an uneventful thymectomy. After two months, the patient&#39;s symptoms were fully alleviated, as evidenced by the reduction in Quantitative MG Score from 9 to 4 points, Myasthenia Gravis Composite Score from 6 to 1 points, Myasthenia Gravis Activities of Daily Living Score from 4 to 1 points, and Myasthenia Gravis Quality of Life-15 score from 14 to 8 points respectively. This case highlights the importance of differentiating autoimmune disorders from hereditary neuromuscular diseases and initiating timely treatment.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39925811/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">39925811</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11802489/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250210091012&v=2.18.0.post9+e462414">PMC11802489</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2025.1498847>10.3389/fimmu.2025.1498847</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39925811</guid><pubDate> Mon, 10 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Xuan Wu</dc:creator><dc:creator> Xiao-Tian Xu</dc:creator><dc:creator>林周</dc:creator><dc:creator>Kai Qiao</dc:creator><dc:creator> Chong-Bo Zhao</dc:creator><dc:creator> Su-Shan Luo</dc:creator><dc:date> 2025-02-10</dc:date><dc:source>免疫学领域</dc:source><dc:title>Distal muscle weakness as the main onset symptom in thymoma-associated myasthenia gravis: a case report and literature review</dc:title><dc:identifier> pmid:39925811</dc:identifier><dc:identifier> pmc:PMC11802489</dc:identifier><dc:identifier> doi:10.3389/fimmu.2025.1498847</dc:identifier></item></channel></rss>